Molecular genetic characterization of myeloid/lymphoid neoplasms associated with eosinophilia and rearrangement of or .
作者信息
Baer Constance, Muehlbacher Verena, Kern Wolfgang, Haferlach Claudia, Haferlach Torsten
机构信息
MLL Munich Leukemia Laboratory, Germany
MLL Munich Leukemia Laboratory, Germany.
出版信息
Haematologica. 2018 Aug;103(8):e348-e350. doi: 10.3324/haematol.2017.187302. Epub 2018 Mar 22.
Abstract
摘要
相似文献
1
Molecular genetic characterization of myeloid/lymphoid neoplasms associated with eosinophilia and rearrangement of or .与嗜酸性粒细胞增多及PDGFRA、PDGFRB或FGFR1重排相关的髓系/淋系肿瘤的分子遗传学特征
Haematologica. 2018 Aug;103(8):e348-e350. doi: 10.3324/haematol.2017.187302. Epub 2018 Mar 22.
2
Hematologic malignancies with PCM1-JAK2 gene fusion share characteristics with myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB, and FGFR1.具有 PCM1-JAK2 基因融合的血液系统恶性肿瘤具有伴嗜酸性粒细胞增多和 PDGFRA、PDGFRB 和 FGFR1 异常的髓系和淋巴系肿瘤的特征。
Ann Hematol. 2013 Jun;92(6):759-69. doi: 10.1007/s00277-013-1695-3. Epub 2013 Feb 12.
3
Myeloid/Lymphoid Neoplasms Associated With Eosinophilia and Rearrangements of PDGFRA, PDGFRB, or FGFR1 or With PCM1-JAK2.伴嗜酸性粒细胞增多和 PDGFRA、PDGFRB 或 FGFR1 重排或伴 PCM1-JAK2 的髓系/淋系肿瘤
Am J Clin Pathol. 2021 Feb 4;155(2):160-178. doi: 10.1093/ajcp/aqaa208.
4
Myeloid neoplasms associated with eosinophilia and rearrangement of PDGFRA, PDGFRB, and FGFR1: a review.伴嗜酸性粒细胞增多和 PDGFRA、PDGFRB、FGFR1 重排的髓系肿瘤：综述。
Int J Lab Hematol. 2013 Oct;35(5):491-500. doi: 10.1111/ijlh.12057. Epub 2013 Mar 13.
5
[Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB or FGFR1].伴有嗜酸性粒细胞增多及血小板衍生生长因子受体α（PDGFRA）、血小板衍生生长因子受体β（PDGFRB）或成纤维细胞生长因子受体1（FGFR1）异常的髓系和淋巴系肿瘤
Zhonghua Bing Li Xue Za Zhi. 2012 Nov;41(11):779-83. doi: 10.3760/cma.j.issn.0529-5807.2012.11.018.
6
[Characteristics of cytogenetics and molecular biology in patients with eosinophilia].嗜酸性粒细胞增多症患者的细胞遗传学和分子生物学特征
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2012 Oct;20(5):1216-20.
7
Myeloid neoplasms with eosinophilia.伴嗜酸性粒细胞增多的髓系肿瘤。
Blood. 2017 Feb 9;129(6):704-714. doi: 10.1182/blood-2016-10-695973. Epub 2016 Dec 27.
8
Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB or FGFR1.伴有嗜酸性粒细胞增多以及PDGFRA、PDGFRB或FGFR1异常的髓系和淋系肿瘤
Haematologica. 2010 May;95(5):696-8. doi: 10.3324/haematol.2009.021675.
9
Myeloid/lymphoid neoplasm associated with eosinophilia and concurrent rearrangement of PDGFRA and FGFR1: A very rare pediatric case.与嗜酸性粒细胞增多及血小板衍生生长因子受体α（PDGFRA）和成纤维细胞生长因子受体1（FGFR1）同时重排相关的髓系/淋系肿瘤：1例极罕见的儿科病例
Pediatr Blood Cancer. 2023 Oct;70(10):e30507. doi: 10.1002/pbc.30507. Epub 2023 Jun 19.
10
Myeloid/Lymphoid Neoplasm with PDGFRB Rearrangement with t (5;10) (q33;q22) Harboring a Novel Breakpoint of the CCDC6-PDGFRB Fusion Gene.伴CCDC6-PDGFRB融合基因新断点的t(5;10)(q33;q22)的PDGFRB重排的髓系/淋系肿瘤
Intern Med. 2019 Dec 1;58(23):3449-3453. doi: 10.2169/internalmedicine.3220-19. Epub 2019 Jul 22.
引用本文的文献
1
Approach to the patient with eosinophilia in the era of tyrosine kinase inhibitors and biologicals.酪氨酸激酶抑制剂和生物制剂时代嗜酸粒细胞增多症患者的处理方法。
Curr Hematol Malig Rep. 2024 Oct;19(5):208-222. doi: 10.1007/s11899-024-00738-7. Epub 2024 Jul 22.
2
Interface-guided phenotyping of coding variants in the transcription factor RUNX1.转录因子 RUNX1 中编码变异的接口引导表型分析。
Cell Rep. 2024 Jul 23;43(7):114436. doi: 10.1016/j.celrep.2024.114436. Epub 2024 Jul 4.
3
Clinical and Therapeutic Intervention of Hypereosinophilia in the Era of Molecular Diagnosis.分子诊断时代高嗜酸性粒细胞增多症的临床与治疗干预
Cancers (Basel). 2024 Mar 31;16(7):1383. doi: 10.3390/cancers16071383.
4
[Guideline of the diagnosis and treatment of eosinophilic disorders (2024)].[嗜酸性粒细胞相关疾病的诊断和治疗指南（2024年）]
Zhonghua Xue Ye Xue Za Zhi. 2024 Jan 14;45(1):1-7. doi: 10.3760/cma.j.cn121090-20231222-00334.
5
A Pediatric Primary Cardiac Spindle Cell Neoplasm With a Rare PDGFRA::USP8 Gene Fusion: A Case Report.儿童原发性心脏梭形细胞肿瘤伴罕见 PDGFRA::USP8 基因融合：病例报告。
Pediatr Dev Pathol. 2024 Jul-Aug;27(4):335-339. doi: 10.1177/10935266231221903. Epub 2024 Feb 24.
6
Approach to Acute Myeloid Leukemia with Increased Eosinophils and Basophils.嗜酸性粒细胞和嗜碱性粒细胞增多的急性髓系白血病的治疗方法
J Clin Med. 2024 Feb 2;13(3):876. doi: 10.3390/jcm13030876.
7
Hematological Neoplasms with Eosinophilia.伴有嗜酸性粒细胞增多的血液系统肿瘤
Cancers (Basel). 2024 Jan 12;16(2):337. doi: 10.3390/cancers16020337.
8
Myeloid/lymphoid neoplasm with rearrangement: A complex trilineage phenotypic and clonal evolution with associated genomic alterations.伴有重排的髓系/淋系肿瘤：一种伴有相关基因组改变的复杂三系表型和克隆性演变。
Leuk Res Rep. 2023 May 26;19:100370. doi: 10.1016/j.lrr.2023.100370. eCollection 2023.
9
The multidisciplinary approach to eosinophilia.嗜酸性粒细胞增多症的多学科治疗方法。
Front Oncol. 2023 May 18;13:1193730. doi: 10.3389/fonc.2023.1193730. eCollection 2023.
10
Myeloid/lymphoid neoplasms associated with eosinophilia and rearrangements of with erythroblastic sarcoma: a case report and literature review.与嗜酸性粒细胞增多及重排相关的髓系/淋系肿瘤伴成红细胞肉瘤：一例报告及文献复习
Haematologica. 2023 Dec 1;108(12):3506-3510. doi: 10.3324/haematol.2022.282228.
本文引用的文献
1
Detection of recurrent and of novel fusion transcripts in myeloid malignancies by targeted RNA sequencing.通过靶向RNA测序检测髓系恶性肿瘤中的复发和新型融合转录本。
Leukemia. 2018 May;32(5):1229-1238. doi: 10.1038/s41375-017-0002-z. Epub 2018 Feb 26.
2
World Health Organization-defined eosinophilic disorders: 2017 update on diagnosis, risk stratification, and management.世界卫生组织定义的嗜酸性粒细胞疾病：2017 年诊断、风险分层和管理更新。
Am J Hematol. 2017 Nov;92(11):1243-1259. doi: 10.1002/ajh.24880.
3
Myeloid neoplasms with eosinophilia.伴嗜酸性粒细胞增多的髓系肿瘤。
Blood. 2017 Feb 9;129(6):704-714. doi: 10.1182/blood-2016-10-695973. Epub 2016 Dec 27.
4
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.2016 年版世界卫生组织髓系肿瘤和急性白血病分类。
Blood. 2016 May 19;127(20):2391-405. doi: 10.1182/blood-2016-03-643544. Epub 2016 Apr 11.
5
Next generation sequencing of myeloid neoplasms with eosinophilia harboring the FIP1L1-PDGFRA mutation.携带FIP1L1-PDGFRA突变的嗜酸性粒细胞增多性髓系肿瘤的下一代测序
Am J Hematol. 2016 Mar;91(3):E10-1. doi: 10.1002/ajh.24273. Epub 2016 Jan 11.
6
Targeted next generation sequencing of PDGFRB rearranged myeloid neoplasms with monocytosis.对伴有单核细胞增多的血小板衍生生长因子受体B（PDGFRB）重排的髓系肿瘤进行靶向二代测序。
Am J Hematol. 2016 Mar;91(3):E12-4. doi: 10.1002/ajh.24267.
7
Acute Myeloid Leukemia.急性髓系白血病
N Engl J Med. 2015 Sep 17;373(12):1136-52. doi: 10.1056/NEJMra1406184.
8
Myeloid and lymphoid neoplasm with abnormalities of FGFR1 presenting with trilineage blasts and RUNX1 rearrangement: a case report and review of literature.伴有FGFR1异常、呈现三系原始细胞及RUNX1重排的髓系和淋系肿瘤：一例报告并文献复习
Am J Clin Pathol. 2015 May;143(5):738-48. doi: 10.1309/AJCPUD6W1JLQQMNA.
9
Specific molecular mutation patterns delineate chronic neutrophilic leukemia, atypical chronic myeloid leukemia, and chronic myelomonocytic leukemia.特定的分子突变模式可区分慢性嗜中性粒细胞白血病、非典型慢性髓性白血病和慢性粒单核细胞白血病。
Haematologica. 2014 Dec;99(12):e244-6. doi: 10.3324/haematol.2014.113159. Epub 2014 Sep 19.
10
A ZMYM2-FGFR1 8p11 myeloproliferative neoplasm with a novel nonsense RUNX1 mutation and tumor lysis upon imatinib treatment.一种伴有新型RUNX1无义突变的ZMYM2 - FGFR1 8p11骨髓增殖性肿瘤及伊马替尼治疗后的肿瘤溶解
Cancer Genet. 2013 Apr;206(4):140-4. doi: 10.1016/j.cancergen.2013.04.001.
Zotero 插件